Kaplan and Sadock's Concise Textbook of Clinical Psychiatry
by Sadock, Benjamin J.; Sadock, Virginia A.Rent Textbook
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Author Biography
Table of Contents
| Preface | p. vii |
| Psychiatric History and Mental Status Examination | p. 1 |
| Physical Illness and Psychiatric Disorder | p. 10 |
| Laboratory Tests in Psychiatry | p. 16 |
| Signs and Symptoms in Psychiatry | p. 21 |
| Classification in Psychiatry | p. 33 |
| Psychiatric Rating Scales | p. 40 |
| Delirium, Dementia, Amnestic, and Other Cognitive Disorders and Mental Disorders Due to a General Medical Condition | p. 46 |
| Overview | p. 46 |
| Delirium | p. 48 |
| Dementia | p. 52 |
| Amnestic Disorders | p. 60 |
| Mental Disorders Due to a General Medical Condition | p. 65 |
| Neuropsychiatric Aspects of HIV Infection and AIDS | p. 80 |
| Substance-Related Disorders | p. 85 |
| Introduction and Overview | p. 85 |
| Alcohol-Related Disorders | p. 90 |
| Amphetamine (or Amphetamine-like)-Related Disorders | p. 105 |
| Caffeine-Related Disorders | p. 110 |
| Cannabis-Related Disorders | p. 114 |
| Cocaine-Related Disorders | p. 117 |
| Hallucinogen-Related Disorders | p. 123 |
| Inhalant-Related Disorders | p. 129 |
| Nicotine-Related Disorders | p. 132 |
| Opioid-Related Disorders | p. 136 |
| Phencyclidine (or Phencyclidine-like)-Related Disorders | p. 142 |
| Sedative-, Hypnotic-, or Anxiolytic-Related Disorders | p. 145 |
| Anabolic-Androgenic Steroid Abuse | p. 150 |
| Other Substance-Related Disorders | p. 152 |
| Schizophrenia | p. 156 |
| Other Psychotic Disorders | p. 178 |
| Schizophreniform Disorder | p. 178 |
| Schizoaffective Disorder | p. 180 |
| Delusional Disorder and Shared Psychotic Disorder | p. 182 |
| Brief Psychotic Disorder, Psychotic Disorder Not Otherwise Specified, and Secondary Psychotic Disorders | p. 190 |
| Culture-Bound Syndromes | p. 195 |
| Mood Disorders | p. 200 |
| Depression and Bipolar Disorder | p. 200 |
| Dysthymia and Cyclothymia | p. 225 |
| Other Mood Disorders | p. 230 |
| Anxiety Disorders | p. 236 |
| Overview | p. 236 |
| Panic Disorder and Agoraphobia | p. 239 |
| Specific Phobia and Social Phobia | p. 247 |
| Obsessive-Compulsive Disorder | p. 253 |
| Posttraumatic Stress Disorder and Acute Stress Disorder | p. 258 |
| Generalized Anxiety Disorder | p. 263 |
| Other Anxiety Disorders | p. 267 |
| Somatoform Disorders | p. 273 |
| Factitious Disorders | p. 287 |
| Dissociative Disorders | p. 293 |
| Human Sexuality | p. 303 |
| Normal Sexuality | p. 303 |
| Abnormal Sexuality and Sexual Dysfunctions | p. 306 |
| Paraphilias and Sexual Disorder Not Otherwise Specified | p. 318 |
| Gender Identity Disorders | p. 326 |
| Eating Disorders | p. 333 |
| Anorexia Nervosa | p. 333 |
| Bulimia Nervosa and Eating Disorder Not Otherwise Specified | p. 338 |
| Obesity | p. 341 |
| Normal Sleep and Sleep Disorders | p. 346 |
| Normal Sleep | p. 346 |
| Sleep Disorders | p. 348 |
| Impulse-Control Disorders Not Elsewhere Classified | p. 360 |
| Adjustment Disorders | p. 371 |
| Personality Disorders | p. 375 |
| Psychosomatic Medicine | p. 393 |
| Consultation-Liaison Psychiatry | p. 400 |
| Psychiatry and Reproductive Medicine | p. 403 |
| Relational Problems | p. 410 |
| Problems Related to Abuse or Neglect | p. 414 |
| Additional Conditions That May Be a Focus of Clinical Attention | p. 421 |
| Emergency Psychiatric Medicine | p. 428 |
| Suicide | p. 428 |
| Other Psychiatric Emergencies | p. 434 |
| Psychotherapies | p. 445 |
| Psychoanalysis and Psychoanalytic Psychotherapy | p. 445 |
| Brief Psychodynamic Psychotherapy | p. 449 |
| Group Psychotherapy, Combined Individual and Group Psychotherapy, and Psychodrama | p. 451 |
| Family Therapy and Couples Therapy | p. 454 |
| Dialectical Behavior Therapy | p. 456 |
| Genetic Counseling | p. 457 |
| Biofeedback | p. 457 |
| Behavior Therapy | p. 458 |
| Cognitive Therapy | p. 461 |
| Hypnosis | p. 463 |
| Interpersonal Therapy | p. 464 |
| Psychiatric Rehabilitation | p. 466 |
| Biological Therapies | p. 468 |
| General Principles of Psychopharmacology | p. 468 |
| Medication-Induced Movement Disorders | p. 472 |
| [alpha subscript 2]-Adrenergic Receptor Agonists: Clonidine and Guanfacine | p. 475 |
| [beta]-Adrenergic Receptor Antagonists | p. 477 |
| Anticholinergics and Amantadine | p. 479 |
| Anticonvulsants: Gabapentin, Pregabalin, Tiagabine, Levetiracetam, Topiramate, and Zonisamide | p. 481 |
| Antihistamines | p. 483 |
| Barbiturates and Similarly Acting Drugs | p. 485 |
| Benzodiazepines and Drugs Acting on Benzodiazepine Receptors | p. 488 |
| Bupropion | p. 492 |
| Buspirone | p. 494 |
| Calcium Channel Inhibitors | p. 495 |
| Carbamazepine and Oxcarbazepine | p. 496 |
| Cholinesterase Inhibitors and Memantine | p. 499 |
| Dantrolene | p. 502 |
| Disulfiram and Acamprosate | p. 502 |
| Dopamine Receptor Agonists and Precursors: Apomorphine, Bromocriptine, Levodopa, Pergolide, Pramipexole, and Ropinirole | p. 504 |
| Dopamine Receptor Antagonists: Typical Antipsychotics | p. 506 |
| Lamotrigine | p. 513 |
| Lithium | p. 514 |
| Melatonin Agonists: Ramelteon and Melatonin | p. 519 |
| Mirtazapine | p. 520 |
| Monoamine Oxidase Inhibitors | p. 521 |
| Nefazodone | p. 524 |
| Opioid Receptor Agonists: Methadone, Buprenorphine, and Levomethadyl | p. 526 |
| Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone | p. 528 |
| Phosphodiesterase-5 Inhibitors | p. 531 |
| Selective Serotonin-Norepinephrine Reuptake Inhibitors | p. 533 |
| Selective Serotonin Reuptake Inhibitors | p. 535 |
| Serotonin-Dopamine Antagonists: Atypical Antipsychotics | p. 542 |
| Sympathomimetics and Related Drugs | p. 548 |
| Thyroid Hormones | p. 552 |
| Trazodone | p. 554 |
| Tricyclics and Tetracyclics | p. 555 |
| Valproate | p. 559 |
| Yohimbine | p. 561 |
| Electroconvulsive Therapy | p. 562 |
| Other Brain Stimulation Methods | p. 566 |
| Child Psychiatry: Assessment, Examination, and Psychological Testing | p. 568 |
| Mental Retardation | p. 575 |
| Learning Disorders | p. 585 |
| Motor Skills Disorder: Developmental Coordination Disorder | p. 592 |
| Communication Disorders | p. 595 |
| Pervasive Developmental Disorders | p. 605 |
| Attention-Deficit Disorders | p. 616 |
| Disruptive Behavior Disorders: Oppositional Defiant Disorder and Conduct Disorder | p. 623 |
| Feeding and Eating Disorders of Infancy or Early Childhood | p. 629 |
| Tic Disorders | p. 634 |
| Elimination Disorders | p. 639 |
| Other Disorders of Infancy, Childhood, and Adolescence | p. 644 |
| Reactive Attachment Disorder of Infancy or Early Childhood | p. 644 |
| Stereotypic Movement Disorder and Disorder of Infancy, Childhood, or Adolescence Not Otherwise Specified | p. 646 |
| Mood Disorders and Suicide in Children and Adolescents | p. 650 |
| Depressive Disorders and Suicide in Children and Adolescents | p. 650 |
| Early-Onset Bipolar Disorders | p. 656 |
| Anxiety Disorders of Infancy, Childhood, and Adolescence | p. 659 |
| Obsessive-Compulsive Disorder of Infancy, Childhood, and Adolescence | p. 659 |
| Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Phobia | p. 662 |
| Selective Mutism | p. 667 |
| Early-Onset Schizophrenia | p. 669 |
| Child Psychiatry: Additional Conditions That May Be a Focus of Clinical Attention | p. 673 |
| Psychiatric Treatment of Children and Adolescents | p. 679 |
| Individual Psychotherapy | p. 679 |
| Group Psychotherapy | p. 682 |
| Residential, Day, and Hospital Treatment | p. 684 |
| Biological Therapies | p. 686 |
| Psychiatric Treatment of Adolescents | p. 690 |
| Geriatric Psychiatry | p. 694 |
| End of Life Care | p. 698 |
| Palliative Care | p. 698 |
| Euthanasia and Physician-Assisted Suicide | p. 700 |
| Clinical-Legal Issues in Psychiatry | p. 703 |
| Ethics in Psychiatry | p. 709 |
| Index | p. 712 |
| Table of Contents provided by Ingram. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.
